Legendary Weed Shop logo mark on dark background

The truth behind cannabis potency: THC and CBD compared

Lab numbers printed on a cannabis jar can look authoritative, yet they rarely tell the full story. In Australia, where most patients access dried flower, oils and pre-rolls through the Therapeutic Goods Administration's Special Access Scheme or an Authorised Prescriber, those figures still shape almost every purchase decision. Learn more about Guide Des Disjoncteurs Différentiels Pour Tableau électrique.

THC and CBD percentages indicate the concentration of the two most studied cannabinoids in a given product. They do not measure how a person will actually feel after using it, nor do they capture the dozens of minor cannabinoids, terpenes and flavonoids that quietly influence each session.

For Australian consumers comparing a 30% THC cartridge in Melbourne with a balanced 10:10 oil in Perth, the printed numbers are only the starting point. Potency is a conversation, not a single statistic.

What THC and CBD actually do in the body

Tetrahydrocannabinol, or THC, binds directly to CB1 receptors in the brain and central nervous system, producing the intoxicating effects most people associate with cannabis. It can ease pain, stimulate appetite and, in higher amounts, trigger anxiety or paranoia. Cannabidiol, or CBD, works more indirectly. It modulates receptor activity, supports the endocannabinoid system and may soften some of THC's less welcome effects.

The way these two compounds interact is known as the entourage effect. A product with 15% THC and 2% CBD can feel markedly different from one with 15% THC and no CBD at all, even though the headline potency looks similar. Patients working with clinics in Sydney and Adelaide often report that adding CBD to a regimen reduces unwanted peaks without removing therapeutic benefits.

It is also worth remembering that the body absorbs cannabinoids differently depending on the delivery method. Inhaled THC enters the bloodstream within minutes, while oral products undergo first-pass liver metabolism, which can change both intensity and duration.

How lab-tested percentages are measured and reported

Most regulated producers send samples to independent laboratories that use high-performance liquid chromatography for non-degraded samples and gas chromatography for dried flower. The result is a certificate of analysis showing cannabinoid percentages by weight.

Reliable instrumentation depends on stable laboratory infrastructure, including properly rated electrical panels and safety devices. Without the protections described in differential circuit breaker guides, power fluctuations could skew analytical results.

This approach is consistent across most regulated markets, including Australia's Office of Drug Control licensed producers and US operators such as legendary weed shop, which publish testing data alongside product descriptions. The methodology is reliable, but the number on the label represents a snapshot of one batch, not every jar on every shelf.

Storage conditions also matter. THC slowly converts to cannabinol when exposed to heat, light and air, which can drop a flower's effective potency over weeks. A six-month-old 25% bud rarely behaves like a fresh one, even if the original lab report said otherwise.

Why higher THC does not always mean stronger effects

Potency chasing has pushed average THC levels in legal markets sharply upward over the past decade. Yet experienced consumers in Brisbane and beyond often find that a 22% flower with a rich terpene profile delivers a more satisfying experience than a 30% bud with little aroma.

Terpenes such as myrcene, limonene and pinene shape the character of a strain far more than the average shopper realises. They influence whether a session feels uplifting, calming or focused, and they can amplify or calm the psychoactive edge of THC. That is why two cultivars with identical THC percentages can feel worlds apart.

Individual biology matters as well. Liver enzyme variations, prior tolerance and even the time of day change how a dose lands. A patient new to medical cannabis generally feels the same THC percentage far more strongly than a daily consumer, a reality that labels cannot capture.

How Australians can read and compare product labels

Australian medical cannabis packaging is regulated by the TGA and must include batch numbers, expiry dates, storage instructions and cannabinoid content in milligrams per gram or millilitre. Many patient-facing platforms translate those figures into percentages to match the language used overseas, which can cause confusion when comparing a 25 mg/mL oil with a 25% flower.

A simple rule of thumb helps. One gram of flower at 20% THC contains 200 mg of THC. A 10 mL bottle at 20 mg/mL contains 200 mg of THC as well. Recognising that both express total cannabinoid load, just in different units, makes cross-category comparisons far clearer for patients and prescribers.

Patients interested in the underlying pharmacology can dig deeper with resources such as cannabinoids and their effects, which walks through receptor activity and dosing in plain language.

Practical ways to evaluate potency before you buy

There is no universal best ratio, only the right starting point for each person. Daytime relief frequently pairs well with equal or higher CBD, while sleep support often calls for THC-dominant formulas paired with small amounts of CBN.

Patients managing chronic pain in regional Victoria and Western Australia often prefer measured formats such as pre-rolls, where the dose is already prepared and consistent. Resources on pre-roll benefits for patients outline why this format suits people who want convenience without sacrificing accuracy.

A short checklist helps cut through the marketing noise.

Once these habits become second nature, the difference between a 28% THC flower and a 12% CBD flower feels far less mysterious. The numbers stop being a sales pitch and start becoming a genuine map of how a product will fit into your day.